BCX4161
BCX4161-104
Phase 3 small_molecule completed
Quick answer
BCX4161 for Hereditary Angioedema is a Phase 3 program (small_molecule) at BIOCRYST PHARMACEUTICALS INC with 4 ClinicalTrials.gov record(s).
Program details
- Company
- BIOCRYST PHARMACEUTICALS INC
- Indication
- Hereditary Angioedema
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed